Abstract
Background Carbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge because of the high morbidity and mortality associated with their infections, especially in developing countries where there may not be many antibiotic treatment options. Despite these challenges, there are few studies in Ghana that have described the burden of CRE. This study aimed to determine the prevalence of carbapenem-resistant Enterobacteriaceae isolated from patients at the Cape Coast Teaching Hospital (CCTH) in the Central region of Ghana.
Methodology/Principal findings Enterobacteriaceae isolates were collected from April to July 2019 at the bacteriology unit of CCTH using a consecutive sampling method. Isolates were identified by standard microbiological techniques and confirmed using API 20E. Kirby Bauer disc diffusion method was used to determine the antibiogram of isolates. Isolates were also subjected to ESBL testing using the single-disc combination method. Carbapenem resistant isolates were identified by the Kirby Bauer disc diffusion method and then subjected to genetic confirmation using polymerase chain reaction (PCR). Of the 230 isolates comprising E. coli (40.9%), Citrobacter spp. (32.6%), K. pneumoniae (9.1%), P. mirabilis (6.1%), P. vulgaris (5.2%), Enterobacter spp (3.5%)., K. oxytoca (2.2%), and Serratia marcenses (0.4%). Majority of the isolates were from urine 162(70.4%) and wound samples. The isolates showed high resistance to ampicillin 171 (74.3%) and cefuroxime 134(58.3%). The prevalence of MDR was 35.2% (81) with E. coli 40(42.6%) being the majority that exhibited MDR. Out of the 230 isolates, 113(49.1%) were ESBL producers with E. coli 54(57.5%) accounting for the majority while Serratia marcenses was the least. Out of the 13 (5.7%) CRE isolates which showed resistance towards carbapenem in the disc diffusion method, 11 expressed the blaNDM-1 gene whilst all isolates which showed resistant CRE expressed the blaOXA-48 gene.
Conclusion The prevalence of carbapenem resistance and ESBL- producing Enterobacteriaceae pathogens among patients at the CCTH, Cape coast of Ghana is high, and effective infection prevention and control measures should be implemented at the hospital to prevent the rapid spread of these dangerous organisms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cape Coast Teaching Hospital Ethical Review Committee (CCTHERC/EC/2019/044) of the Cape Coast Teaching Hospital and Committee on Human Research, Publication and Ethics (CHRPE/AP/201/19) of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology jointly approved the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying the results presented in the study will be made available